US FDA defines small number of animals for minor use designation
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued a final rule defining what constitutes a “small number of animals” under the Minor Use and Minor Species Animal Health Act. The MUMS act offers incentives to pharma companies wanting to develop drugs for minor species and for uncommon diseases in major species1,2.